First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXH · Real-Time Price · USD
39.40
+0.40 (1.03%)
At close: Aug 5, 2026, 4:00 PM EDT
39.35
-0.05 (-0.13%)
After-hours: Aug 5, 2026, 7:34 PM EDT
FTXH Holdings Information
FTXH is an equity ETF with a total of 51 individual holdings. The top holdings are Eli Lilly and Company stock at 7.21%, AbbVie at 7.17%, Bristol-Myers Squibb Company at 7.12%, Merck & Co. at 7.00%, and Johnson & Johnson at 6.95%.
Total Holdings
51
Top 10 Percentage
53.15%
Asset Class
Equity
ETF Category
Health
Assets
912.25M
PE Ratio
21.93
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 7.21% |
| 2 | ABBV | AbbVie Inc. | 7.17% |
| 3 | BMY | Bristol-Myers Squibb Company | 7.12% |
| 4 | MRK | Merck & Co., Inc. | 7.00% |
| 5 | JNJ | Johnson & Johnson | 6.95% |
| 6 | VTRS | Viatris Inc. | 4.01% |
| 7 | BIIB | Biogen Inc. | 3.57% |
| 8 | CAH | Cardinal Health, Inc. | 3.49% |
| 9 | AMGN | Amgen Inc. | 3.32% |
| 10 | REGN | Regeneron Pharmaceuticals, Inc. | 3.31% |
| 11 | VRTX | Vertex Pharmaceuticals Incorporated | 3.22% |
| 12 | PFE | Pfizer Inc. | 3.07% |
| 13 | GILD | Gilead Sciences, Inc. | 2.99% |
| 14 | UTHR | United Therapeutics Corporation | 2.60% |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 2.58% |
| 16 | INCY | Incyte Corporation | 2.49% |
| 17 | ILMN | Illumina, Inc. | 2.23% |
| 18 | ZTS | Zoetis Inc. | 1.99% |
| 19 | EXEL | Exelixis, Inc. | 1.74% |
| 20 | MEDP | Medpace Holdings, Inc. | 1.52% |
| 21 | CRL | Charles River Laboratories International, Inc. | 1.51% |
| 22 | NBIX | Neurocrine Biosciences, Inc. | 1.34% |
| 23 | ALKS | Alkermes plc | 1.27% |
| 24 | HALO | Halozyme Therapeutics, Inc. | 1.27% |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 1.16% |
As of Aug 2, 2026